CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hebei Changshan Biochemical Pharmaceutical Co Ltd Company Snapshot
Hebei Changshan Biochemical Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hebei Changshan Biochemical Pharmaceutical Co Ltd with three other companies in this sector in China: Huaren Pharmaceutical Co Ltd (2017 sales of 1.31 billion Chinese Renmimbi [US$191.57 million] of which 89% was Medicine Industry), Yantai Dongcheng Pharmaceutical Group Co Ltd (1.60 billion Chinese Renmimbi [US$233.01 million] of which 37% was Nuclides), and Asymchem Laboratories Tian Jin Co Ltd (1.42 billion Chinese Renmimbi [US$207.81 million] of which 100% was Pharmaceutical industry).

Sales Analysis. Hebei Changshan Biochemical Pharmaceutical Co Ltd reported sales of 1.42 billion Chinese Renmimbi (US$207.39 million) for the year ending December of 2017. This represents an increase of 27.0% versus 2016, when the company's sales were 1.12 billion Chinese Renmimbi. Sales at Hebei Changshan Biochemical Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 147%). Sales of Others saw an increase that was more than double the company's growth rate: sales were up 266.0% in 2017, from 372,096.42 Chinese Renmimbi to 1.36 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hebei Changshan Biochemical Pharmaceutical Co Ltd
  Stock Performance Chart for Hebei Changshan Biochemical Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/21/2018): 4.75
(Figures in Chinese Renmimbi)
1 Week -1.5%   13 Weeks -2.9%  
4 Weeks -7.0%   52 Weeks -46.7%  
 
Hebei Changshan Biochemical Pharmaceutical Co Ltd Key Data:
  Ticker: 300255 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 1,420,161,448
(Year Ending Jan 2018).
Employees: 808
  Currency: Chinese Renmimbi Market Cap: 4,441,092,671
  Fiscal Yr Ends: December Shares Outstanding: 934,966,878
  Share Type: Class A Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.